Sciensano

MARCH 7, 2024

In our very first episode, titled “Patient Involvement in Policy Making”, we had the privilege of speaking with Katlijn Sanctorum from the Familial Adenomatous Polyposis Association ( FAPA ) and Wannes Van Hoof from Sciensano. Stay connected with us as we continue to bring you updates and insights through the BE - EBCP Mirror group.

52

52

Pharma in Brief

OCTOBER 26, 2023

The Patented Medicine Prices Review Board ( PMPRB ) has announced a framework for the launch of its consultation on new guidelines, beginning with a scoping paper to be published in advance of Policy Roundtable sessions to be held December 5 (English) and December 6 (French), 2023.

Medicine 52

Medicine Drugs Pharmacy Regulation 52

Drug Channels

MAY 30, 2022

Let’s turn up the heat with these sizzling news bites straight from the Drug Channels grill: SaveonSP gets sued Thoughts on the Medicaid accumulator rule opinion CVS buys AmerisourceBergen’s specialty pharmacy Fresh data on hospitals’ cancer drug profiteering Plus, Dr. Glaucomflecken explains Aetna’s prior authorization policies.

Pharmacy 74

Pharmacy Drugs 74

Pharmaceutical Technology

MAY 12, 2023

Matinas announced the news in a May 10 statement. The news means the collaboration between the two companies lasted just over a year. BioNTech has ended its research collaboration with Matinas after its oral mRNA vaccine failed to demonstrate preclinical activity.

Vaccination 130

Vaccination Vaccine In-Vivo In-Vitro 130

World of DTC Marketing

NOVEMBER 24, 2021

The com­pa­ny said the drug would be priced at a WAC of about $39,000 per month, or $468,000 per year and their stock immediately rose 25% on the news. The drug is rapamycin in a new albumin coating. Rapamycin was approved in 1999 and it’s also worth noting their Phase II was a tiny patient population.

Drugs 266

Drugs FDA Approval Research Medicine 266

Pharmaceutical Technology

JANUARY 27, 2023

This news illustrates how NICE is determined to get the best care to patients fast, while ensuring value for money for the taxpayer.” NICE medicines evaluation director Helen Knight said: “I am delighted that we have been able to recommend this pioneering treatment for people.

Gene Therapy 147

Gene Therapy Clinical Trials Clinical Trials Gene 147

Scienmag

JUNE 7, 2021

. — New research from Binghamton University, State University of New York shows the human trauma and family separation that resulted from the Trump Administration’s zero tolerance policy on undocumented immigration.

Research 40

Research 40

The Pharma Data

JANUARY 6, 2021

AAP Outlines Principles Guiding School COVID-19 Policies. Researchers provide guidance to support communities, local leadership in education and public health, and pediatricians collaborating with schools to create policies for safe schools during the COVID-19 pandemic. More News Resources. Professional. WEDNESDAY, Jan.

Development 52

Development Research 52

Pharmacy Checkers

OCTOBER 15, 2020

A surrogate for the Trump campaign, Katy Talento, stated in an interview with Elisabeth Rosenthal, Editor-in-Chief, Kaiser Health News, that personal drug importation is allowed as a means for Americans to afford prescription drugs. Read Kaiser Health News: Amid Pandemic, FDA Seizes Cheaper Drugs From Canada. pharmacy shelves?

Pharmacy 94

Pharmacy Drugs 94

Camargo

JANUARY 14, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. FDA Clarifies Policies on CRLs, Inspections, and COVID-19. In the News: March 2021 Regulatory and Development Updates.

Development 148

Development Production FDA Approval Drugs 148

WCG Clinical

APRIL 3, 2023

Each business day, the new FDAnews will deliver precisely what pharmaceutical and medical device manufacturers have told us they need to know about regulatory compliance and good manufacturing practices,” said Terri Moench, RPh, MS, President, Research Solutions for WCG.

Compliance 52

Compliance Drugs Manufacturing Regulation 52

Drug Channels

FEBRUARY 28, 2023

I am pleased to report that this month’s Drug Channels news roundup was most definitely not written by ChatGPT. The era of artificial-intelligence chatbots has arrived! No promises about future articles. See our forecast to the right.) P.S. Join my nearly 38,000 LinkedIn followers for daily links to neat stuff.

Drugs 71

Drugs Generic Drugs 71

The Pharma Data

JUNE 12, 2021

Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. This site is governed solely by applicable U.S. laws and governmental regulations. Your use of the information on this site is subject to the terms of our Legal Notice.

Regulation 40

Regulation 40

The Pharma Data

MAY 7, 2021

Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. This site is governed solely by applicable U.S. laws and governmental regulations. Your use of the information on this site is subject to the terms of our Legal Notice.

Regulation 40

Regulation 40

Intouch Solutions

DECEMBER 7, 2022

Justin Chase, SVP, Media, EVERSANA INTOUCH, was recently interviewed by Endpoints News for an article on how pharmaceutical companies are handling both paid and organic interaction on Twitter in the era of Elon Musk ownership. It really is a challenge with so many Americans using the platform and valuing the platform.”

Life Science 52

Life Science Pharma Companies Branding Marketing 52

Sciensano

FEBRUARY 9, 2023

The socioeconomic impact of environmental stressors is significant, yet there exists a gap in policy initiatives. The BEST - COST framework will enable researchers and policymakers to adopt a harmonised approach, and to make use of improved economic and health modelling in policy impact assessments.

Research 52

Research Development 52

Drug Discovery World

JANUARY 5, 2024

News round-up for 1-5 January by DDW Digital Content Editor Diana Spencer. The start of 2024 has seen quite a bit of regulatory activity, with the UK MHRA’s launch of a new procedure for assessing drugs, along with significant regulatory approvals for therapeutics for cytomegalovirus, melanoma, amyloidosis and multiple sclerosis.

Drugs 52

Drugs Medicine Regulation Production 52

Rethinking Clinical Trials

OCTOBER 27, 2022

In a recent paper, Health advertising on Facebook: Privacy and Policy Considerations, patients download their raw data, and found who was tracking them across the internet. Three out of 5 companies included in the study were not adhering to their privacy policies. Health advertising on Facebook: Privacy and policy considerations.

Clinical Research 130

Clinical Research Research Clinical Trials Clinical Trials 130

Drug Channels

OCTOBER 29, 2020

Since we can’t trick-or-treat, spend some time with our spooky roundup of Drug Channels news stories: Creepy! UnitedHealthcare expects physicians to enforce its copay accumulator policy Vampiric! Halloween is truly scary this year. How GoodRx sucks money from the channel Shocking! You can also join my followers on LinkedIn.)

Drugs 40

Drugs Pharmacy 40

Intouch Solutions

JULY 18, 2023

It’s gone from a news-breaking, joke-slinging, social-commentary hot spot to a place of hatred, racism and vitriol. Still, 50% of America gets their news from social media, and 30% only get their news from social media, so Twitter hasn’t been a platform you could afford to divest from. Until now, perhaps.

Branding 75

Branding Marketing 75

The Pharma Data

OCTOBER 21, 2020

21, 2020 — One of the reasons women may be less vulnerable to COVID-19 is because they’re more likely to adhere to social distancing policies, a new survey suggests. Women were also ahead of men in terms of agreeing with public policies and following them. WEDNESDAY, Oct. The study was published Oct.

Compliance 52

Compliance 52

World of DTC Marketing

SEPTEMBER 23, 2021

Now, we are asking you to do something equally important to educate yourself regarding policies that will help our breakthroughs get into the hands of those who need them while protecting our sector’s ability to develop those breakthroughs in the first place.”. That is our horse s**t. Then there is the tale of Biogen.

Vaccination 214

Vaccination Vaccine Drugs Packaging 214

Worldwide Clinical Trials

APRIL 5, 2024

Together, the community highlighted: 15 posts talking about Rare Disease Day or featuring events happening or coming up in the rare disease communities 7 news announcements 12 posts related to drug development 22 posts related to advocacy or personal experiences 6 posts about policies impacting rare communities 12 posts featuring valuable resources (..)

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

FDA Law Blog

SEPTEMBER 19, 2023

Last week, the FTC held a Listening Session about the listing of patents in the Orange Book, which concluded with a unanimous vote to issue a Policy Statement. Importantly though, the Policy Statement does not provide any insight into the types of listings that do not meet the statutory criteria and thus would be considered anticompetitive.

Drugs 105

Drugs Branding Drug Delivery Systems Generic Drugs 105

XTalks

JULY 7, 2023

Understanding the Hospital Price Transparency Rule Recent health policy changes in the US have been directed towards enhancing cost transparency in the healthcare industry. A key policy contributing to this change is the Hospital Price Transparency Final Rule, which was implemented on January 1, 2021.

Regulation 98

Regulation Marketing Licensing Licensing 98

Drug Discovery World

SEPTEMBER 7, 2023

The poll saw 76% of respondents state that the new UK-EU relationship had caused difficulties in recruiting and retaining research staff.

Research 59

Research Scientist Vaccination Vaccine 59

The Pharma Data

OCTOBER 19, 2020

emergency sick leave provision in the Families First Coronavirus Response Act (FFCRA) was a highly effective policy tool to flatten the curve in the short run, according to a report published online Oct. More News Resources. Professional. Emergency Sick Leave Helped to Flatten the U.S. COVID-19 Curve. MONDAY, Oct. 15 in Health Affairs.

Containment 52

Containment Research 52

pharmaphorum

OCTOBER 23, 2020

Novartis announced the news at the virtual XEFFERVESCENCE Digital and AI in the Healthcare Industry event, attended by government officials and members of the healthcare industry. Canada is investing to position itself as a world-leading destination for AI innovation.

Pharma Companies 123

Pharma Companies Development Research 123

The Pharma Data

DECEMBER 29, 2020

from the University of Michigan Institute for Healthcare Policy and Innovation in Ann Arbor, and colleagues surveyed a national sample of adults (aged 50 to 80 years) about their experiences with emergency department visits. More News Resources. Professional. One in Four Older Adults Have Used Emergency Dept in Past Few Years.

52

52

Triage Cancer

JULY 6, 2021

Engaging in policy and legislative advocacy is more important than ever. We have revamped our Advocacy Resources to include: New State and Federal Legislative Tracking Charts. These charts share information about policy and legislative issues that may impact the cancer community at both the federal and state levels. Stay tuned.

Genetics 52

Genetics 52

The Pharma Data

DECEMBER 30, 2020

“Policies should seek to reduce exposure to structural and environmental risks and to ensure equitable opportunities to achieve optimal health among racial/ethnic minorities and immigrants,” the authors write. More News Resources. Professional. Ongoing Exposure to Stressors Harms Health. WEDNESDAY, Dec. Abstract/Full Text.

Medicine 52

Medicine Research 52

Pharma in Brief

JANUARY 11, 2023

On December 20, 2022, the government of Ontario announced a new policy to expand the use of biosimilar drugs in the province. Ontario is the eighth jurisdiction in Canada to expand the use of biosimilar drugs, following British Columbia, Alberta, New Brunswick, Quebec, the Northwest Territories, Nova Scotia, and Saskatchewan.

Drugs 52

Drugs Production Marketing Life Science 52

The Pharma Data

DECEMBER 2, 2020

2, 2020 — At a Special Meeting of the AMA House of Delegates, the American Medical Association (AMA) adopted a new policy to advocate for widespread adoption of telehealth beyond the COVID-19 pandemic. More News Resources. Professional. AMA Pushes for Widespread Telehealth Adoption. WEDNESDAY, Dec. More Information.

Regulation 52

Regulation 52

Triage Cancer

DECEMBER 8, 2020

by Michelle Andrews, Kaiser Health News. It’s just disgusting that these companies expect Joe Schmo or a guy like me to interpret [these policies] and then get screwed in the end,” Bloechl said. So, the policy may never pay out.”. He worked with a different broker, and he had lawyers look over the policies he was considering.

Sales 98

Sales Insulin Doctors Doctor 98

Sciensano

AUGUST 4, 2022

Scientists of the Working Group of Science Advice for Policy by European Academies ( SAPEA ), among which Sciensano’s Dr. Marc Arbyn , a leading scientist in the area of cervical cancer, have written an Evidence Review Report as part of the EU ’s Scientific Opinion on Cancer Screening in Europe. Read the letter. Cancer centre.

Scientist 52

Scientist 52

Camargo

OCTOBER 14, 2020

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The post In the News: September Regulatory and Development Updates appeared first on Camargo. FDA Establishes Digital Health Center of Excellence.

Development 196

Development Insulin Drug Delivery Production 196

The Pharma Data

JANUARY 26, 2021

“This information is important to inform and help evaluate state and local-level tobacco control policies such as state-, city-, or county-level tobacco taxes and smoke-free air laws; investments in tobacco prevention; and increasing access to smoking cessation resources,” Islami said in a statement. More News Resources.

Research 52

Research 52